NCT05891886View on ClinicalTrials.gov

Supplemental Oxygen in Pulmonary Embolism (SO-PE)

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Pulmonary EmbolismVenous ThromboembolismMetabolomicsOxygen Inhalation Therapy
Interventions
DRUG

Oxygen Therapy

Study subjects will be asked to breathe supplemental, or extra, oxygen during several time periods.

DEVICE

Non-rebreather mask

Non-rebreather mask is a non-invasive oxygen supplementation device that is used to provide continuous oxygen flow, typically in a hospital setting.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Aarhus University Hospital

OTHER

lead

Massachusetts General Hospital

OTHER